Related Experiment Videos
[A new system for permanent venous access, Cathlink 20: prospective clinical study. 95 cases]
F Lakdja1, N Roubault, J M Fonrouge
1Département d'Anesthésie-Réanimation, Institut Bergonié, Centre Regional de Lutte Contre le Cancer, Bordeaux, France.
Pathologie-Biologie
|April 24, 1999
Summary
This study evaluated the Cathlink venous access system in 95 cancer patients. The system demonstrated improved safety and efficacy for long-term venous access, despite initial access challenges.
Area of Science:
- Oncology
- Medical Devices
- Vascular Access
Background:
- Cancer patients often require long-term venous access for treatment.
- Conventional implantable devices can have limitations in terms of safety and usability.
- Evaluating novel venous access systems is crucial for improving patient care.
Purpose of the Study:
- To assess the safety and efficacy of the Cathlink venous access system.
- To compare Cathlink with conventional implantable catheter devices.
- To evaluate the clinical performance of Cathlink in cancer patients.
Main Methods:
- Prospective clinical study involving 95 cancer patients requiring long-term venous access (≥3 months).
- Implantation of Cathlink low and standard profile systems in the prethoracic region.
- Evaluation of device safety, efficacy, and access success rates.
Main Results:
- Successful first-try access in 79% of 493 instances.
- Improved flow and catheter location compared to conventional devices.
- Enhanced safety, including reduced infection risk due to no needle recoil.
Conclusions:
- The Cathlink system offers a safe and effective option for long-term venous access in cancer patients.
- While initial access may be challenging, improvements are expected with newer versions.
- The system provides enhanced safety and is perceived positively by healthcare professionals.